TIMP2 and ovarian cancer: Overall, the staining of these tumours indicates that TIMP-2 expression was reduced in the tumours originating from gRNA1 and gRNA2 cells, compared to parental and control tumours and these tumours were of human ovarian cancer origin (express CA125) (Fig. 12).